Astaxanthin vs CoQ10
Two lipid-soluble antioxidants marketed for skin and 'anti-aging energy' — one with a real positive heart-failure mortality trial, the other with decent small skin-photoaging data and little else.
Astaxanthin
A potent lipid-phase carotenoid antioxidant with decent small-trial data for skin photoaging — but the endpoints are surrogate markers, the trials are small and industry-linked, and 'strongest antioxidant' is overstated.
Full Astaxanthin evidence reviewCoQ10
Coenzyme Q10, ubiquinone, ubiquinol
Q-SYMBIO showed a real reduction in cardiovascular mortality and hospitalization when added to standard heart-failure therapy — a hard outcome, not a surrogate. Migraine prevention data are real but more modest; statin-myopathy relief did not beat placebo in meta-analysis. The 'declines with age, so restore it' pitch aimed at healthy adults has no supporting outcome trial.
Full CoQ10 evidence reviewSide by side
| Astaxanthin | CoQ10 | |
|---|---|---|
| Marketed for | Skin, antioxidant | Heart failure adjunct, statin-myopathy relief, migraine prevention, general anti-aging 'energy' |
| Evidence grade | Clinical data | Clinical data |
| Family | NAD⁺ & mitochondrial | NAD⁺ & mitochondrial |
| Key human source | Ito, Nutrients 2018 (UV skin RCT) | Q-SYMBIO, JACC Heart Failure 2014 |
marks a row where the two differ. Evidence grades come from our evidence matrix, which grades each molecule on the human data for the use it is marketed for.
Our verdict
CoQ10 has the far stronger clinical case: a real reduction in cardiovascular mortality in heart-failure patients (Q-SYMBIO), and a genuine role in mitochondrial ATP production. Astaxanthin's best human data is smaller and more surrogate-marker-focused — decent skin-photoaging trials, but industry-linked and short. Both get marketed as general 'anti-aging' antioxidants well beyond what either trial base supports for healthy people.
Astaxanthin fits if
Skin appearance specifically is the target, understanding the trials are small and mostly industry-funded.
CoQ10 fits if
You want the antioxidant with an actual positive mortality-outcome trial, particularly relevant if heart failure or statin-related muscle symptoms are a concern.